Contamination of hybrid hernia meshes compared to bioresorbable Phasix™ Mesh in a rabbit subcutaneous implant inoculation model

Background Hybrid hernia meshes combine biological tissue-derived extracellular matrix with permanent or resorbable synthetic. The objective of this study was to evaluate hybrid meshes (Gore® Synecor, Zenapro™, Ovitex™ 1S Reinforced Bioscaffold Permanent, and Ovitex™ 1S Reinforced Bioscaffold Resorbable) compared to non-hybrid, bioresorbable synthetic mesh (Phasix™ Mesh) in a rabbit bacterial inoculation model. Materials and methods Subcutaneous pockets were bilaterally created in male, New Zealand White rabbits (n = 25). Circular meshes (3.8 cm diameter) were implanted and inoculated with 1 × 106 colony forming units (CFU) of clinically-isolated methicillin-resistant Staphylococcus aureus (MRSA). A given animal received a single mesh type. Seven days post-inoculation, animals were euthanized and white material and microbial colonization were assessed by abscess scoring and CFU quantification, respectively. Non-parametric Kruskal-Wallis with Dunn's post-hoc tests compared results for different meshes. Results Phasix™ Mesh and Synecor exhibited significantly lower abscess scores than Zenapro™, Ovitex™ 1S Permanent, and Ovitex™ 1S Resorbable (p < 0.05). All pocket swabs for Zenapro™ and Ovitex™ meshes were positive for MRSA (100%), with 20% of Synecor and 0% Phasix™ Mesh. Microbial colonization was significantly lower for Phasix™ Mesh (0 CFU) relative to Zenapro™ (6.73 × 107 CFU (median)), Ovitex™ 1S Permanent (7.87 × 107 CFU) and Ovitex™ 1S Resorbable (1.45 × 108 CFU), and for Synecor (0 CFU) relative to both Ovitex™ meshes. Phasix™ Mesh was the only device with no detectable abscess or microbial colonization. Conclusion Phasix™ Mesh demonstrated no detectable abscess or microbial colonization at 7-days post-implantation and inoculation, in contrast with four hybrid meshes, which all demonstrated colonization in a rabbit bacterial inoculation model.

[1]  D. Edelman Hybrid mesh for sports hernia repair , 2017 .

[2]  Maureen Martin,et al.  Prevalence of Methicillin-Resistant Staphylococcus aureus in Elective Surgical Patients at a Public Teaching Hospital: An Analysis of 1039 Patients , 2012, The American surgeon.

[3]  J. Spector,et al.  Comparison of Antibiotic-Coated versus Uncoated Porcine Dermal Matrix , 2016, Plastic and reconstructive surgery.

[4]  H. C. van der Mei,et al.  In Vivo Evaluation of Bacterial Infection Involving Morphologically Different Surgical Meshes , 2010, Annals of surgery.

[5]  Chad E. Johnson,et al.  Histological and adhesiogenic characterization of the Zenapro Hybrid Hernia Repair Device , 2016 .

[6]  Y. Novitsky,et al.  In vitro infectability of prosthetic mesh by methicillin-resistant Staphylococcus aureus , 2006, Hernia.

[7]  B. Klosterhalfen,et al.  Functional and morphological evaluation of a low-weight, monofilament polypropylene mesh for hernia repair. , 2002, Journal of biomedical materials research.

[8]  H. Humphreys Staphylococcus aureus: the enduring pathogen in surgery. , 2012, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[9]  S. Ferzoco,et al.  Early experience outcome of a reinforced Bioscaffold in inguinal hernia repair: A case series , 2018 .

[10]  Y. Novitsky,et al.  Evaluation of the Antimicrobial Efficacy of a Novel Rifampin/Minocycline-Coated, Noncrosslinked Porcine Acellular Dermal Matrix Compared With Uncoated Scaffolds for Soft Tissue Repair , 2016, Surgical innovation.

[11]  C. Deeken,et al.  Characterization of host response, resorption, and strength properties, and performance in the presence of bacteria for fully absorbable biomaterials for soft tissue repair , 2017, Hernia.

[12]  M. Citron,et al.  Efficacy of Local Rifampin/Minocycline Delivery (AIGISRX®) to Eliminate Biofilm Formation on Implanted Pacing Devices in a Rabbit Model , 2010, The International journal of artificial organs.

[13]  E. Verdaasdonk,et al.  Long-term Follow-up of a Randomized Controlled Trial of Suture Versus Mesh Repair of Incisional Hernia , 2004, Annals of surgery.

[14]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[15]  M. Rosen,et al.  Does Presoaking Synthetic Mesh in Antibiotic Solution Reduce Mesh Infections? An Experimental Study , 2013, Journal of Gastrointestinal Surgery.

[16]  G. Jacobsen,et al.  A Current Review of Hybrid Meshes in Abdominal Wall Reconstruction , 2018, Plastic and reconstructive surgery.

[17]  N. Turner,et al.  4-Hydroxybutyrate Promotes Endogenous Antimicrobial Peptide Expression in Macrophages. , 2019, Tissue engineering. Part A.

[18]  Guoping Chen,et al.  Evaluation of diaphragmatic hernia repair using PLGA mesh–collagen sponge hybrid scaffold: an experimental study in a rat model , 2008, Pediatric Surgery International.

[19]  E. Pauli,et al.  First human use of hybrid synthetic/biologic mesh in ventral hernia repair: a multicenter trial , 2018, Surgical Endoscopy.

[20]  J. Jeekel,et al.  A comparison of suture repair with mesh repair for incisional hernia. , 2000, The New England journal of medicine.